Sharks are often the subject of TV specials or news stories focusing on their attacks on humans. But scientists are finding that sharks could inspire a new type of surface that would attack bacteria, helping humans instead of hurting them. As reported in ACS Applied Materials & Interfaces, researchers have designed a coating that is infused with antimicrobial agents and has the patterned diamond-like texture of shark skin.
Fighting bacteria is an ongoing battle, resulting in more than 2 million infections and 23,000 deaths in the U.S. every year, according to the Centers for Disease Control and Prevention (CDC). As a result of overusing antibiotics, bacterial resistance to these drugs is on the rise. Patients in hospitals who are already battling illnesses or have compromised immune systems are especially at risk of developing infections just by touching contaminated bedrails and door knobs. Scientists have been developing coatings for these high-touch surfaces to fight the spread and growth of microbes. For example, Sharklet AF™ is a coating designed to mimic a shark's skin, and it reduces the ability of bacteria to adhere to surfaces. But long-term use will result in bacteria accumulation. James J. Watkins, Jessica D. Schiffman and colleagues wanted to see if adding titanium dioxide (TiO2) nanoparticles, which are antibacterial, to a shark skin material would efficiently fight off microbes.
The team printed their own shark skin surfaces with polymer and ceramic composites, and added titanium dioxide nanoparticles to them. The shark skin surface without nanoparticles reduced the attachment of E. coli by 70 percent compared to smooth films. But shark skin surfaces with TiO2 nanoparticles exposed to UV light for one hour killed off over 95 percent of E. coli and 80 percent of Staphylococcus aureus. The group says the fabrication method could be scaled up for mass production.
The authors acknowledge funding from the U.S. Army Laboratories, the National Institutes of Health and the National Science Foundation NRT program.
Source: American Chemical Society
Understanding the True Threat: Richard Webby, PhD, on H5N1 Avian Flu and Its Human Impact
January 3rd 2025Richard Webby, PhD, the director of the World Health Organization (WHO) Collaborating Centre or Studies on the Ecology of Influenza in Animals and Birds, discusses the evolving dynamics of H5N1 avian flu, its variants, and the low risk to humans while emphasizing vigilance among health care professionals.
Top 7 Infection Control Today Articles of 2024: Insights and Innovations
December 30th 2024From advanced sterilization methods to combating antimicrobial resistance, Infection Control Today’s top articles of 2024 delivered actionable strategies for safer healthcare environments and improved patient outcomes.
Revolutionizing Infection Prevention: How Fewer Hand Hygiene Observations Can Boost Patient Safety
December 23rd 2024Discover how reducing hand hygiene observations from 200 to 50 per unit monthly can optimize infection preventionists' time, enhance safety culture, and improve patient outcomes.
Redefining Competency: A Comprehensive Framework for Infection Preventionists
December 19th 2024Explore APIC’s groundbreaking framework for defining and documenting infection preventionist competency. Christine Zirges, DNP, ACNS-BC, CIC, FAPIC, shares insights on advancing professional growth, improving patient safety, and navigating regulatory challenges.
Addressing Post-COVID Challenges: The Urgent Need for Enhanced Hospital Reporting Metrics
December 18th 2024Explore why CMS must expand COVID-19, influenza, and RSV reporting to include hospital-onset infections, health care worker cases, and ER trends, driving proactive prevention and patient safety.